共 50 条
- [5] Risk factor for the development of surgical site infection following ileostomy reversal: a single-center report [J]. Updates in Surgery, 2022, 74 : 1675 - 1682
- [7] Idarucizumab for Reversal of Dabigatran: Single-Center Real-World Experience [J]. American Journal of Cardiovascular Drugs, 2019, 19 : 59 - 64